In This Article:
BrightSpring Health Services (NASDAQ:BTSG) Full Year 2024 Results
Key Financial Results
-
Revenue: US$11.3b (up 28% from FY 2023).
-
Net loss: US$18.1m (loss narrowed by 88% from FY 2023).
-
US$0.094 loss per share (improved from US$1.31 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
BrightSpring Health Services EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates.
Looking ahead, revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 7.1% growth forecast for the Healthcare industry in the US.
Performance of the American Healthcare industry.
The company's shares are down 10% from a week ago.
Balance Sheet Analysis
While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. See our latest analysis on BrightSpring Health Services' balance sheet health.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.